AMDCP Credit Designation: This session has been approved for a total of 1 Management credit hours toward certification as a Certified Medical Director in Long Term Care (CMD).
The American Medical Directors Association designates this educational activity fora maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Presenter(s): Peter V. Rabins, MD, MPH Disclosure(s): Peter V. Rabins, MD has no relevant financial relationships to disclose. Session Description: Cutting-edge genomic technologies are being used to find andunderstand the molecular and genetic contributors to aging and memory. This isjust one of the areas that Dr. Peter Rabins addresses in his presentation onthe latest and promising advances in Alzheimer’s disease research. Dr. Rabinshas focused his career on research defining the psychiatric complications ofstructural brain disease, specifically Alzheimer’s disease. Dr. Rabinstranslates research into practice by discussing the identification, treatment,and prevention of memory disorders. He also shares practical advice for bothpatient and caregiver in the day-to-day challenges facing people with the earlystages of dementia and Alzheimer’s disease. Learning Objectives:
Describe the state of affairs in research in dementia
Interpret the latest research and translate it into practice for longterm care professionals in the long term care setting
Predict the direction of future research and its impact on thediagnosis, treatment and/or management of dementia in the frail elderly